Leslie Trigg Sells 3,445 Shares of Outset Medical (NASDAQ:OM) Stock

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 3,445 shares of the company’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $3.70, for a total value of $12,746.50. Following the sale, the chief executive officer owned 98,874 shares of the company’s stock, valued at $365,833.80. This trade represents a 3.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Outset Medical Trading Up 13.5%

Shares of NASDAQ OM opened at $4.38 on Thursday. The company has a debt-to-equity ratio of 0.87, a current ratio of 6.29 and a quick ratio of 4.97. The stock has a market capitalization of $81.21 million, a P/E ratio of -1.05 and a beta of 1.92. Outset Medical, Inc. has a 1-year low of $3.00 and a 1-year high of $21.98. The business has a fifty day moving average price of $3.96 and a 200 day moving average price of $4.58.

Outset Medical (NASDAQ:OM) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.83) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.79) by ($0.04). The company had revenue of $27.86 million for the quarter, compared to analysts’ expectations of $28.90 million. Outset Medical had a negative return on equity of 56.13% and a negative net margin of 63.65%. Equities research analysts expect that Outset Medical, Inc. will post -3.84 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Legal & General Group Plc purchased a new position in shares of Outset Medical in the second quarter worth about $34,000. BNP Paribas Financial Markets raised its stake in shares of Outset Medical by 7,013.8% in the second quarter. BNP Paribas Financial Markets now owns 2,063 shares of the company’s stock worth $40,000 after purchasing an additional 2,034 shares during the last quarter. New York State Common Retirement Fund purchased a new position in shares of Outset Medical in the second quarter worth about $108,000. Los Angeles Capital Management LLC purchased a new position in shares of Outset Medical in the fourth quarter worth about $29,000. Finally, Quantbot Technologies LP purchased a new position in shares of Outset Medical in the second quarter worth about $152,000.

Analysts Set New Price Targets

Several research analysts recently issued reports on OM shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Outset Medical in a research report on Friday, March 27th. TD Cowen reaffirmed a “buy” rating on shares of Outset Medical in a research report on Friday, May 8th. BTIG Research reduced their target price on Outset Medical from $17.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday, February 12th. Finally, Wall Street Zen lowered Outset Medical from a “hold” rating to a “sell” rating in a research report on Saturday, April 11th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $10.00.

Outset Medical Company Profile

Outset Medical is a medical technology company specializing in innovations for renal care. The company’s flagship offering, the Tablo Hemodialysis System, is designed to streamline and simplify dialysis treatment across acute and outpatient settings. By integrating water purification, dialysate production, and treatment monitoring into a single device, Tablo aims to reduce the complexity and logistical burden traditionally associated with hemodialysis therapy.

Tablo’s modular design allows for rapid setup and flexible deployment in hospitals, clinics, long?term care facilities and emergency response scenarios.